US Stock MarketDetailed Quotes

SILO Silo Pharma

Watchlist
  • 1.380
  • +0.060+4.55%
Close Mar 14 16:00 ET
  • 1.380
  • +0.000+0.01%
Post 17:13 ET
6.19MMarket Cap-1.19P/E (TTM)

About Silo Pharma Company

Silo Pharma, Inc. is a developmental stage biopharmaceutical company, which engages in the merging of traditional therapeutics with psychedelic research. It seeks to acquire and develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs. The company was founded by Eric Weisblum on July 13, 2010 and is headquartered in Sarasota, FL.

Company Profile

SymbolSILO
Company NameSilo Pharma
Listing DateSep 27, 2022
Founded2010
CEOMr. Eric Weisblum
MarketNASDAQ
Employees3
Fiscal Year Ends12-31
Address677 North Washington Boulevard
CitySarasota
ProvinceFlorida
CountryUnited States of America
Zip Code34236
Phone1-718-400-9031

Company Executives

  • Name
  • Position
  • Salary
  • Eric Weisblum
  • Chairman of the Board, Chief Executive Officer and President
  • 569.01K
  • Daniel E. Ryweck
  • Chief Financial Officer and Principal Accounting Officer
  • 62.69K
  • Wayne D. Linsley
  • Independent Director
  • 45.00K
  • Dr. Kevin Munoz
  • Independent Director
  • 25.00K
  • Dr. Jeff Pavell, M.D.
  • Independent Director
  • 25.00K

Trending Stocks

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More